Medicare Enrolled

Dr. Kathryn Shunnarah, ARNP

Physician Assistant · Rockledge, FL
Low-engagement
107 LONGWOOD AVE, Rockledge, FL 32955
3216362111
In practice since 2006 (19 years)
NPI: 1699837104 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shunnarah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shunnarah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shunnarah

Dr. Kathryn Shunnarah is a physician assistant in Rockledge, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Shunnarah received a total of $16,406 from 74 pharmaceutical and/or device companies across 684 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shunnarah is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $16,406 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$16,406
Total received (2021-2024)
Avg $4,101/year across 4 years
Top 1% in FL for physician assistant
74
Companies
684
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,578 (76.7%)
Other
Charitable contributions, space rental, and other categories
$3,204 (19.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$624 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,914
2023
$3,518
2022
$3,331
2021
$3,642

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,314
NOVARTIS PHARMACEUTICALS CORPORATION
$1,312
Janssen Biotech, Inc.
$1,262
AstraZeneca Pharmaceuticals LP
$1,064
PFIZER INC.
$1,011
Merck Sharp & Dohme LLC
$916
Amgen Inc.
$724
Lilly USA, LLC
$605
Seagen Inc.
$582
Astellas Pharma US Inc
$517
GENZYME CORPORATION
$486
Incyte Corporation
$388
Takeda Pharmaceuticals U.S.A., Inc.
$373
Daiichi Sankyo Inc.
$366
Celgene Corporation
$322
Eisai Inc.
$255
Regeneron Healthcare Solutions, Inc.
$250
Genentech USA, Inc.
$219
E.R. Squibb & Sons, L.L.C.
$197
Karyopharm Therapeutics Inc.
$179
Merck Sharp & Dohme Corporation
$178
Ipsen Biopharmaceuticals, Inc
$136
BeiGene USA, Inc.
$131
Bayer HealthCare Pharmaceuticals Inc.
$123
Celltrion USA Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$117
Mirati Therapeutics, Inc.
$116
ABBVIE INC.
$115
GlaxoSmithKline, LLC.
$100
SANOFI-AVENTIS U.S. LLC
$98
Sumitomo Pharma America, Inc.
$92
Myovant Sciences Inc.
$89
Agios Pharmaceuticals, Inc.
$83
ARRAY BIOPHARMA INC
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
JAZZ PHARMACEUTICALS INC.
$77
PUMA BIOTECHNOLOGY, INC.
$76
Deciphera Pharmaceuticals Inc.
$71
SERVIER PHARMACEUTICALS LLC
$69
EISAI INC.
$65
Pharmacyclics LLC, An AbbVie Company
$64
AVEO Pharmaceuticals, Inc.
$60
Coherus Biosciences Inc.
$60
Puma Biotechnology, Inc.
$55
PharmaEssentia USA Corporation
$52
Epizyme, Inc.,
$50
SOBI, INC
$50
Pharmacosmos Therapeutics Inc.
$44
ADC Therapeutics America, Inc.
$44
Heron Therapeutics, Inc.
$43
Pharmacyclics LLC, an AbbVie Company
$38
EMD Serono, Inc.
$37
Genmab U.S., Inc.
$34
Clovis Oncology, Inc.
$33
TerSera Therapeutics LLC
$29
Biocon Biologics Inc
$25
Rigel Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$24
CTI BioPharma Corp.
$24
TG THERAPEUTICS, INC.
$23
Exelixis Inc.
$23
Mylan Institutional Inc.
$22
TAIHO ONCOLOGY, INC.
$21
Taiho Oncology, Inc.
$18
AbbVie Inc.
$18
AMAG Pharmaceuticals, Inc.
$17
Iovance Biotherapeutics, Inc.
$16
G1 Therapeutics, Inc.
$16
Acceleron Pharma, Inc.
$16
Stemline Therapeutics Inc.
$15
Sobi, Inc
$14
Novocure Inc.
$14
Dova Pharmaceuticals
$13
Global Blood Therapeutics, Inc.
$13
Top 3 companies account for 29.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · Aliqopa · Amtagvi · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cinvanti · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tecentriq Hybreza · UKONIQ · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VONVENDI · Vanflyta · Venclexta · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for physician assistant in FL.

Looking for a physician assistant in Rockledge?
Compare physician assistants in the Rockledge area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
218
Per 100K population
35.1
County median income
$75,817
Nearest hospital
ORLANDO HEALTH ROCKLEDGE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shunnarah is a physician assistant, and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Shunnarah receive payments from pharmaceutical companies?
Yes. Dr. Shunnarah received a total of $16,406 from 74 companies across 684 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Shunnarah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →